Discover Oncology : Impact Factor & More
eISSN: 2730-6011pISSN: 2730-6011
Open AccessShare this on:
Key Metrics
CiteScore 
5.1
Impact Factor
< 5
SJR
Q2Oncology
SNIP
1.15
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Discover Oncology
Discover Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SPRINGER |
| Language | English |
| Frequency | Bi-monthly |
| Article Processing Charges | EUR 1140 | USD 1520 | GBP 1040 |
| Publication Time | 5 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Discover Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Discover Oncology
Predictive value of apparent diffusion coefficient, plasma levels of placental growth factor and glial fibrillary acidic protein, and their combinations for patients with recurrent glioblastoma.
- 1 Jul 2026
- Discover oncology
A bibliometric and visualized analysis of CAR-T or TCR-T in solid tumor (from 2015 to 2024).
- 1 Jul 2026
- Discover oncology
Metformin in endometrial cancer from metabolic regulation to precision therapeutics.
- 1 Jul 2026
- Discover oncology
Adipocytes in cancer a metabolic paradox and the dawn of novel therapeutics.
- 30 Jun 2026
- Discover oncology
Dual roles of mesenchymal, neural, and induced pluripotent stem cells in cancer: implications for tumorigenesis and therapeutic applications.
- 30 Jun 2026
- Discover oncology
Global prevalence and disability-adjusted life years of hepatoblastoma in children aged 0 to 4 years.
- 30 Jun 2026
- Discover oncology
Predictive value of apparent diffusion coefficient, plasma levels of placental growth factor and glial fibrillary acidic protein, and their combinations for patients with recurrent glioblastoma.
- 1 Jul 2026
- Discover oncology
A bibliometric and visualized analysis of CAR-T or TCR-T in solid tumor (from 2015 to 2024).
- 1 Jul 2026
- Discover oncology
Metformin in endometrial cancer from metabolic regulation to precision therapeutics.
- 1 Jul 2026
- Discover oncology
Adipocytes in cancer a metabolic paradox and the dawn of novel therapeutics.
- 30 Jun 2026
- Discover oncology
Dual roles of mesenchymal, neural, and induced pluripotent stem cells in cancer: implications for tumorigenesis and therapeutic applications.
- 30 Jun 2026
- Discover oncology
Global prevalence and disability-adjusted life years of hepatoblastoma in children aged 0 to 4 years.
- 30 Jun 2026
- Discover oncology
FAQs on Discover Oncology
What is the publishing frequency of Discover Oncology? 
How many articles did Discover Oncology publish last year?
What is the eISSN & pISSN for Discover Oncology?
What is Citescore for Discover Oncology?
What is SNIP score for Discover Oncology?
What is the SJR for Discover Oncology?
Who is the publisher of Discover Oncology?
